Showing 1 - 10 of 101
Kennedys has urged the Irish Government to change the way the personal injury discount rate is calculated to reflect what injured people actually do with their compensation in real life.
Kennedys has urged the Northern Ireland Executive to change the way the personal injury discount rate is calculated to reflect what injured people do with their compensation in real life. This is in response to a consultation issued by Stormont, which our Belfast office has responded to drawing upon the experiences of the firm’s national offices.
Our latest thinking into the insurance impacts arising from the ongoing crisis is offered against England entering Phase 3 of its recovery plan, with large parts of the economy opening for socially distanced service for the first time since early March.
A summary of key developments including an update on bereavement damages in England and Wales, the postponement of the whiplash reforms, an update on QOCS in Scotland, research into remote hearings, the FCA’s test case on business interruption cover during the coronavirus pandemic and consultation on the discount rate in Ireland and Northern Ireland.
Our latest thinking into the insurance impacts arising from the ongoing crisis is offered against the Office for National Statistics having confirmed that the UK economy shrank by 20.4% in April, the largest monthly contraction on record.
The results of Part 2 of the Law Commissions’ joint consultation into the regulation of automated vehicles, “emphasised how uncertain the future has become, and how regulation must be sufficiently flexible to deal with a wide variety of eventualities.”
To put it mildly, COVID-19 has been a game-changer in the personal injury sector. That includes the scope of purchased insurance products and their coverage.
Our latest thinking into the insurance impacts arising from the ongoing crisis is offered against the Prime Minister, Boris Johnson, having confirmed that the five tests which must be satisfied before lockdown can be adjusted have been met.
This report looks at who currently bears the cost of funding personal care for those with catastrophic injuries, and the need to better manage these costs in future.
Our latest thinking into the insurance impacts arising from the ongoing crisis is offered against a positive step in the UK exit strategy. Abbott and Roche have now both been approved to provide COVID-19 antibody tests in the UK.